Holen Sie sich die Stockscreener-App
41.18
0.81%
0.33
Handel nachbörslich:
41.18
Schlusskurs vom Vortag:
$40.85
Offen:
$40.9
24-Stunden-Volumen:
1.13M
Relative Volume:
0.75
Marktkapitalisierung:
$6.45B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
64.68
EPS:
0.6367
Netto-Cashflow:
-
1W Leistung:
+7.27%
1M Leistung:
+33.88%
6M Leistung:
+229.97%
1J Leistung:
+210.56%
1-Tages-Spanne:
$40.75
$42.62
1-Wochen-Bereich:
$37.55
$42.62
52-Wochen-Spanne:
$7.50
$42.62
Pacs Group Inc Stock (PACS) Company Profile
Firmenname
Pacs Group Inc
Sektor
Branche
Telefon
(801) 447-9829
Adresse
262 N. UNIVERSITY AVENUE, FARMINGTON
Vergleichen Sie PACS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PACS
Pacs Group Inc
|
41.18 | 6.40B | 0 | 0 | 0 | 0.6367 |
|
HCA
Hca Healthcare Inc
|
470.65 | 110.35B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
202.00 | 18.30B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.85 | 13.72B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
208.39 | 13.85B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
106.37 | 10.84B | 5.51B | 494.70M | 386.40M | 4.84 |
Pacs Group Inc Stock (PACS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-06 | Fortgesetzt | JP Morgan | Overweight |
| 2024-10-09 | Eingeleitet | UBS | Buy |
| 2024-09-11 | Fortgesetzt | Citigroup | Buy |
| 2024-06-28 | Eingeleitet | Macquarie | Outperform |
| 2024-05-06 | Eingeleitet | Citigroup | Buy |
| 2024-05-06 | Eingeleitet | JP Morgan | Overweight |
| 2024-05-06 | Eingeleitet | Oppenheimer | Outperform |
| 2024-05-06 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-05-06 | Eingeleitet | Stephens | Overweight |
| 2024-05-06 | Eingeleitet | Truist | Buy |
Alle ansehen
Pacs Group Inc Aktie (PACS) Neueste Nachrichten
RBC Capital reiterates Outperform rating on PACS Group stock By Investing.com - Investing.com UK
PACS Group Inc stock hits 52-week high at 41.18 USD - Investing.com India
PACS Group, Inc. (PACS) Stock Analysis: Unpacking a 31% Revenue Growth and 11% Potential Upside - DirectorsTalk Interviews
Is PACS Group Inc. stock dividend yield sustainable2026 world cup usa national team quarterfinals midfield engines possession football group prediction statistical analysis - ulpravda.ru
How PACS Group Inc. stock benefits from global expansionPrice-to-Book Ratio Updates & Maximize Gains Professionally - bollywoodhelpline.com
PACS Group Inc Stock Analysis and ForecastSwing Trading Watchlist & Affordable Capital Growth - earlytimes.in
PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-01-01 | PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:PACS | Press Release - Stockhouse
PACS Group stock hits 52-week high at 39.42 USD By Investing.com - Investing.com Nigeria
Bronstein, Gewirtz & Grossman, LLC Encourages PACS Group, Inc. (PACS) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
PACS Group stock hits 52-week high at 39.42 USD - Investing.com India
Bronstein, Gewirtz & Grossman, LLC Is Investigating PACS Group, Inc. (PACS) And Encourages Shareholders to Connect - ACCESS Newswire
2025-12-28 | Bronstein, Gewirtz & Grossman, LLC Is Investigating PACS Group, Inc. (PACS) And Encourages Shareholders to Connect | NYSE:PACS | Press Release - Stockhouse
Earnings Recap: Why PACS Group Inc stock attracts global investorsGold Moves & Daily Volume Surge Trade Alerts - moha.gov.vn
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PACS Group, Inc. (PACS) And Encourages Shareholders to Reach Out - ACCESS Newswire
PACS Group stockholders endorse directors, auditor and pay - The Globe and Mail
PACS Group (PACS) investors approve directors, auditor and annual pay vote - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages PACS Group, Inc. (PACS) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
PACS Group stock hits 52-week high at 37.06 USD By Investing.com - Investing.com Nigeria
PACS Group is the top performing healthcare facilities' stock YTD (PACS:NYSE) - Seeking Alpha
PACS Group stock hits 52-week high at 37.06 USD - Investing.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PACS Group, Inc. (PACS) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
PACS Group (PACS) Price Target Increased by 17.62% to 36.89 - Nasdaq
How Investors May Respond To PACS Group (PACS) Strengthening Compliance And HR Leadership After Recent Deals - simplywall.st
PACS Group stock price target raised to $47 from $33 at RBC Capital - ca.investing.com
PACS Group (PACS) director receives 4,399 RSUs vesting in 2026 - Stock Titan
PACS Group (PACS) director reports 4,399 restricted stock unit award - Stock Titan
PACS Group (PACS) details RSU grants to chief accounting officer - Stock Titan
PACS Group (PACS) grants RSUs to chief legal officer in Form 4 - Stock Titan
[Form 4] PACS Group, Inc. Insider Trading Activity - Stock Titan
Will PACS Group Inc. stock outperform Dow Jones indexPortfolio Gains Report & AI Powered Trade Plan Recommendations - DonanımHaber
Why PACS Group Inc. stock attracts global investors2025 Stock Rankings & Momentum Based Trading Ideas - DonanımHaber
What sentiment indicators say about PACS Group Inc. stock2025 Dividend Review & AI Enhanced Trading Signals - Улправда
RBC Boosts Price Target on PACS Group to $47 From $33, Keeps Outperform Rating - marketscreener.com
Why PACS Group Inc. stock is rated strong buy2025 Biggest Moves & Long-Term Growth Stock Strategies - DonanımHaber
UBS reiterates PACS Group (PACS) buy recommendation - MSN
Is PACS Group Inc. stock recession proofWeekly Trading Summary & Reliable Breakout Stock Forecasts - Улправда
PACS Group resumed with a buy at UBS - MSN
PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Pacs Group resumed with a Buy at UBS - TipRanks
PACS: UBS Adjusts Price Target, Maintains Buy Rating | PACS Stoc - GuruFocus
PACS Group stock price target lowered to $42 by UBS on valuation - Investing.com Canada
JP Morgan Reiterates PACS Group (PACS) Overweight Recommendation - MSN
PACS Insider Trading - Quiver Quantitative
PACS Group (PACS): JP Morgan Reinstates Coverage with Overweight Rating | PACS Stock News - GuruFocus
PACS Group reinstated with an overweight at JPMorgan - MSN
Buy Recommendation for PACS Group Inc.: Strategic Expansion in Skilled Nursing Facilities with Strong Growth Potential - TipRanks
Pacs Group reinstated with an Overweight at JPMorgan - TipRanks
PACS Group stock rating reinstated as Overweight by JPMorgan - Investing.com Canada
Bronstein, Gewirtz & Grossman, LLC Is Investigating PACS Group, Inc. (PACS) And Encourages Investors to Connect - ACCESS Newswire
PACS Group stock hits 52-week high at 35.53 USD - Investing.com
Finanzdaten der Pacs Group Inc-Aktie (PACS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):